The global market for Brucella Melitensis Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Brucella Melitensis Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Brucella Melitensis Vaccine by region & country, by Type, and by Application.

The Brucella Melitensis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucella Melitensis Vaccine.

Market Segmentation

Scope of Brucella Melitensis Vaccine - Market Report

Report Metric	Details
Report Name	Brucella Melitensis Vaccine - Market
CAGR	5%
Segment by Type:	Live Vaccines Attenuated Vaccines
Segment by Application	Commercial Farming Enterprise Private Farming
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CZ Veterinaria, JOVAC, Dollvet, Antigen, Jinyu, Onderstepoort, VETAL Animal Health Products Inc., MSD Animal Health, Hester Biosciences Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Brucella Melitensis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Brucella Melitensis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Brucella Melitensis Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Brucella Melitensis Vaccine - Market report?

Ans: The main players in the Brucella Melitensis Vaccine - Market are CZ Veterinaria, JOVAC, Dollvet, Antigen, Jinyu, Onderstepoort, VETAL Animal Health Products Inc., MSD Animal Health, Hester Biosciences Limited

What are the Application segmentation covered in the Brucella Melitensis Vaccine - Market report?

Ans: The Applications covered in the Brucella Melitensis Vaccine - Market report are Commercial Farming Enterprise, Private Farming

What are the Type segmentation covered in the Brucella Melitensis Vaccine - Market report?

Ans: The Types covered in the Brucella Melitensis Vaccine - Market report are Live Vaccines, Attenuated Vaccines

1 Market Overview

1.1 Brucella Melitensis Vaccine Product Introduction

1.2 Global Brucella Melitensis Vaccine Market Size Forecast

1.2.1 Global Brucella Melitensis Vaccine Sales Value (2019-2030)

1.2.2 Global Brucella Melitensis Vaccine Sales Volume (2019-2030)

1.2.3 Global Brucella Melitensis Vaccine Sales Price (2019-2030)

1.3 Brucella Melitensis Vaccine Market Trends & Drivers

1.3.1 Brucella Melitensis Vaccine Industry Trends

1.3.2 Brucella Melitensis Vaccine Market Drivers & Opportunity

1.3.3 Brucella Melitensis Vaccine Market Challenges

1.3.4 Brucella Melitensis Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Brucella Melitensis Vaccine Players Revenue Ranking (2023)

2.2 Global Brucella Melitensis Vaccine Revenue by Company (2019-2024)

2.3 Global Brucella Melitensis Vaccine Players Sales Volume Ranking (2023)

2.4 Global Brucella Melitensis Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Brucella Melitensis Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Brucella Melitensis Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Brucella Melitensis Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Brucella Melitensis Vaccine

2.9 Brucella Melitensis Vaccine Market Competitive Analysis

2.9.1 Brucella Melitensis Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Brucella Melitensis Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Melitensis Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Live Vaccines

3.1.2 Attenuated Vaccines

3.2 Global Brucella Melitensis Vaccine Sales Value by Type

3.2.1 Global Brucella Melitensis Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Brucella Melitensis Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Brucella Melitensis Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Brucella Melitensis Vaccine Sales Volume by Type

3.3.1 Global Brucella Melitensis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Brucella Melitensis Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Brucella Melitensis Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Brucella Melitensis Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Commercial Farming Enterprise

4.1.2 Private Farming

4.2 Global Brucella Melitensis Vaccine Sales Value by Application

4.2.1 Global Brucella Melitensis Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Brucella Melitensis Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Brucella Melitensis Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Brucella Melitensis Vaccine Sales Volume by Application

4.3.1 Global Brucella Melitensis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Brucella Melitensis Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Brucella Melitensis Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Brucella Melitensis Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Brucella Melitensis Vaccine Sales Value by Region

5.1.1 Global Brucella Melitensis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Brucella Melitensis Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Brucella Melitensis Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Brucella Melitensis Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Brucella Melitensis Vaccine Sales Volume by Region

5.2.1 Global Brucella Melitensis Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Brucella Melitensis Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Brucella Melitensis Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Brucella Melitensis Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Brucella Melitensis Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Brucella Melitensis Vaccine Sales Value, 2019-2030

5.4.2 North America Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Brucella Melitensis Vaccine Sales Value, 2019-2030

5.5.2 Europe Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Brucella Melitensis Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Brucella Melitensis Vaccine Sales Value, 2019-2030

5.7.2 South America Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Brucella Melitensis Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Brucella Melitensis Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Brucella Melitensis Vaccine Sales Value

6.2.1 Key Countries/Regions Brucella Melitensis Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Brucella Melitensis Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Brucella Melitensis Vaccine Sales Value, 2019-2030

6.3.2 United States Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Brucella Melitensis Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Brucella Melitensis Vaccine Sales Value, 2019-2030

6.4.2 Europe Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Brucella Melitensis Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Brucella Melitensis Vaccine Sales Value, 2019-2030

6.5.2 China Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Brucella Melitensis Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Brucella Melitensis Vaccine Sales Value, 2019-2030

6.6.2 Japan Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Brucella Melitensis Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Brucella Melitensis Vaccine Sales Value, 2019-2030

6.7.2 South Korea Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Brucella Melitensis Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Brucella Melitensis Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Brucella Melitensis Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Brucella Melitensis Vaccine Sales Value, 2019-2030

6.9.2 India Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Brucella Melitensis Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 CZ Veterinaria

7.1.1 CZ Veterinaria Company Information

7.1.2 CZ Veterinaria Introduction and Business Overview

7.1.3 CZ Veterinaria Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 CZ Veterinaria Brucella Melitensis Vaccine Product Offerings

7.1.5 CZ Veterinaria Recent Development

7.2 JOVAC

7.2.1 JOVAC Company Information

7.2.2 JOVAC Introduction and Business Overview

7.2.3 JOVAC Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 JOVAC Brucella Melitensis Vaccine Product Offerings

7.2.5 JOVAC Recent Development

7.3 Dollvet

7.3.1 Dollvet Company Information

7.3.2 Dollvet Introduction and Business Overview

7.3.3 Dollvet Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Dollvet Brucella Melitensis Vaccine Product Offerings

7.3.5 Dollvet Recent Development

7.4 Antigen

7.4.1 Antigen Company Information

7.4.2 Antigen Introduction and Business Overview

7.4.3 Antigen Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Antigen Brucella Melitensis Vaccine Product Offerings

7.4.5 Antigen Recent Development

7.5 Jinyu

7.5.1 Jinyu Company Information

7.5.2 Jinyu Introduction and Business Overview

7.5.3 Jinyu Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Jinyu Brucella Melitensis Vaccine Product Offerings

7.5.5 Jinyu Recent Development

7.6 Onderstepoort

7.6.1 Onderstepoort Company Information

7.6.2 Onderstepoort Introduction and Business Overview

7.6.3 Onderstepoort Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Onderstepoort Brucella Melitensis Vaccine Product Offerings

7.6.5 Onderstepoort Recent Development

7.7 VETAL Animal Health Products Inc.

7.7.1 VETAL Animal Health Products Inc. Company Information

7.7.2 VETAL Animal Health Products Inc. Introduction and Business Overview

7.7.3 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Offerings

7.7.5 VETAL Animal Health Products Inc. Recent Development

7.8 MSD Animal Health

7.8.1 MSD Animal Health Company Information

7.8.2 MSD Animal Health Introduction and Business Overview

7.8.3 MSD Animal Health Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 MSD Animal Health Brucella Melitensis Vaccine Product Offerings

7.8.5 MSD Animal Health Recent Development

7.9 Hester Biosciences Limited

7.9.1 Hester Biosciences Limited Company Information

7.9.2 Hester Biosciences Limited Introduction and Business Overview

7.9.3 Hester Biosciences Limited Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Hester Biosciences Limited Brucella Melitensis Vaccine Product Offerings

7.9.5 Hester Biosciences Limited Recent Development

8 Industry Chain Analysis

8.1 Brucella Melitensis Vaccine Industrial Chain

8.2 Brucella Melitensis Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Brucella Melitensis Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Brucella Melitensis Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

VETAL Animal Health Products Inc.

MSD Animal Health

Hester Biosciences Limited

List of Tables

Table 1. Brucella Melitensis Vaccine Market Trends

Table 2. Brucella Melitensis Vaccine Market Drivers & Opportunity

Table 3. Brucella Melitensis Vaccine Market Challenges

Table 4. Brucella Melitensis Vaccine Market Restraints

Table 5. Global Brucella Melitensis Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Brucella Melitensis Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Brucella Melitensis Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Brucella Melitensis Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Brucella Melitensis Vaccine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Brucella Melitensis Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Brucella Melitensis Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Brucella Melitensis Vaccine

Table 13. Global Brucella Melitensis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Melitensis Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Brucella Melitensis Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Brucella Melitensis Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Brucella Melitensis Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Brucella Melitensis Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Brucella Melitensis Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Brucella Melitensis Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Brucella Melitensis Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Brucella Melitensis Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Brucella Melitensis Vaccine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Brucella Melitensis Vaccine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Brucella Melitensis Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Brucella Melitensis Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Brucella Melitensis Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Brucella Melitensis Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Brucella Melitensis Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Brucella Melitensis Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Brucella Melitensis Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Brucella Melitensis Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Brucella Melitensis Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Brucella Melitensis Vaccine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Brucella Melitensis Vaccine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Brucella Melitensis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Brucella Melitensis Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Brucella Melitensis Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Brucella Melitensis Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Brucella Melitensis Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Brucella Melitensis Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Brucella Melitensis Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Brucella Melitensis Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Brucella Melitensis Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Brucella Melitensis Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Brucella Melitensis Vaccine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Brucella Melitensis Vaccine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Brucella Melitensis Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Brucella Melitensis Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Brucella Melitensis Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Brucella Melitensis Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Brucella Melitensis Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. CZ Veterinaria Company Information

Table 58. CZ Veterinaria Introduction and Business Overview

Table 59. CZ Veterinaria Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. CZ Veterinaria Brucella Melitensis Vaccine Product Offerings

Table 61. CZ Veterinaria Recent Development

Table 62. JOVAC Company Information

Table 63. JOVAC Introduction and Business Overview

Table 64. JOVAC Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. JOVAC Brucella Melitensis Vaccine Product Offerings

Table 66. JOVAC Recent Development

Table 67. Dollvet Company Information

Table 68. Dollvet Introduction and Business Overview

Table 69. Dollvet Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Dollvet Brucella Melitensis Vaccine Product Offerings

Table 71. Dollvet Recent Development

Table 72. Antigen Company Information

Table 73. Antigen Introduction and Business Overview

Table 74. Antigen Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Antigen Brucella Melitensis Vaccine Product Offerings

Table 76. Antigen Recent Development

Table 77. Jinyu Company Information

Table 78. Jinyu Introduction and Business Overview

Table 79. Jinyu Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Jinyu Brucella Melitensis Vaccine Product Offerings

Table 81. Jinyu Recent Development

Table 82. Onderstepoort Company Information

Table 83. Onderstepoort Introduction and Business Overview

Table 84. Onderstepoort Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Onderstepoort Brucella Melitensis Vaccine Product Offerings

Table 86. Onderstepoort Recent Development

Table 87. VETAL Animal Health Products Inc. Company Information

Table 88. VETAL Animal Health Products Inc. Introduction and Business Overview

Table 89. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Offerings

Table 91. VETAL Animal Health Products Inc. Recent Development

Table 92. MSD Animal Health Company Information

Table 93. MSD Animal Health Introduction and Business Overview

Table 94. MSD Animal Health Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. MSD Animal Health Brucella Melitensis Vaccine Product Offerings

Table 96. MSD Animal Health Recent Development

Table 97. Hester Biosciences Limited Company Information

Table 98. Hester Biosciences Limited Introduction and Business Overview

Table 99. Hester Biosciences Limited Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Hester Biosciences Limited Brucella Melitensis Vaccine Product Offerings

Table 101. Hester Biosciences Limited Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Brucella Melitensis Vaccine Downstream Customers

Table 105. Brucella Melitensis Vaccine Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Brucella Melitensis Vaccine Product Picture

Figure 2. Global Brucella Melitensis Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Brucella Melitensis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Brucella Melitensis Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Brucella Melitensis Vaccine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Brucella Melitensis Vaccine Report Years Considered

Figure 7. Global Brucella Melitensis Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Brucella Melitensis Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucella Melitensis Vaccine Revenue in 2023

Figure 10. Brucella Melitensis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Live Vaccines Picture

Figure 12. Attenuated Vaccines Picture

Figure 13. Global Brucella Melitensis Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Brucella Melitensis Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Brucella Melitensis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Brucella Melitensis Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Brucella Melitensis Vaccine Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Commercial Farming Enterprise

Figure 19. Product Picture of Private Farming

Figure 20. Global Brucella Melitensis Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Brucella Melitensis Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Brucella Melitensis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Brucella Melitensis Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Brucella Melitensis Vaccine Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Brucella Melitensis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Brucella Melitensis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Brucella Melitensis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Brucella Melitensis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Brucella Melitensis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Brucella Melitensis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Brucella Melitensis Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Brucella Melitensis Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Brucella Melitensis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Brucella Melitensis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Brucella Melitensis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Brucella Melitensis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Brucella Melitensis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Brucella Melitensis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Brucella Melitensis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Brucella Melitensis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Brucella Melitensis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Brucella Melitensis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Brucella Melitensis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Brucella Melitensis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Brucella Melitensis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Brucella Melitensis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Brucella Melitensis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Brucella Melitensis Vaccine Industrial Chain

Figure 59. Brucella Melitensis Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions